Nearly 74% of all overdose deaths linked to cocaine now involve synthetic opioids, such as fentanyl. This trend – multiple drugs used in combination – is part of the rapidly evolving overdose crisis. Xylazine, a non-opioid sedative commonly known as 'tranq,' is also increasingly detected in fentanyl-related deaths. In addition, there is an ongoing need for care and treatment for substance use disorders (SUD), particularly medically assisted treatment (MAT).
In this webinar from the National Institute for Health Care Management (NIHCM) Foundation, an esteemed panel of experts will delve into these issues and discuss solutions and strategies to reduce drug overdose rates. Speakers will cover:
- The latest federal priorities for addressing the overdose and addiction epidemic, including a focus on drugs used in combination and treatment efforts.
- On-the-ground harm reduction efforts, including increasing access to naloxone, test strips, and syringe service programs.
- Innovative approaches within health plans to combat SUD through prevention, mitigation, recovery, and treatment.